๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Mortality in Parkinson's disease: A 20-year follow-up study

โœ Scribed by Anja Diem-Zangerl; Klaus Seppi; Gregor K. Wenning; Eugen Trinka; Gerhard Ransmayr; Wilhelm Oberaigner; Werner Poewe


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
143 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

We determined mortality rates and predictors of survival in 238 consecutive patients with Parkinson's disease (PD) with symptom onset between 1974 and 1984. All patients were regularly followed at the Movement Disorder Clinic (Department of Neurology at the Innsbruck Medical University) until December 31, 2004, or death. As of December 31, 2004, 189 patients had died. Standardized mortality ratios (SMRs) increased over time. SMRs were 0.6 (95% CI 0.4โ€“1.0) by 5 years, 0.9 (95% CI 0.7โ€“1.2) by 10 years, 1.2 (95% CI 1.0โ€“1.4) by 15 years, and 1.3 (95% CI 1.1โ€“1.5) by 20 to 30 years. SMR for male patients was significantly increased to 1.3 (95% CI 1.1โ€“1.6), whereas SMR increase of 1.2 (0.9โ€“1.4) observed in female patients was not significant. Significantly increased SMRs were detected in patients with younger and older age of onset. Male gender, gait disorder, lack of tremor, and lack of asymmetry as presenting clinical features predicted poor survival in a Cox's proportional hazard analysis. This study demonstrates similar survival of patients with PD to the normal control population up to a disease duration of 10 years, followed by a modest rise of mortality with disease duration beyond 10 years compared with the general population. Under regular specialist care using all currently available therapies life expectancy in PD does not appear seriously compromised, but male gender, gait disorder, and absent rest tremor at presentation are associated with poorer longโ€term survival. ยฉ 2009 Movement Disorder Society


๐Ÿ“œ SIMILAR VOLUMES


Motor complications in Parkinson's disea
โœ Iria Cabo Lรณpez; Pedro J. Garcรญa Ruiz; Silvia Vรกzquez Fernรกndez del Pozo; Vicent ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 159 KB ๐Ÿ‘ 1 views

## Abstract Parkinson's disease (PD) can be symptomatically controlled with standard treatments; however, after a few years, this response typically declines and most patients develop motor complications. We carried out a prospective practiceโ€based study to evaluate the evolution appearance and evo

Fatigue in Parkinson's disease: a nine-y
โœ J.H. Friedman; H. Friedman ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 21 KB ๐Ÿ‘ 1 views

## Abstract Fatigue affects about 50% of Parkinson's disease (PD) patients and is frequently one of its most disabling aspects. It does not correlate with disease severity or duration but does correlate with depression. Fatigue and depression are distinct symptoms and fatigue often fails to respond

Hallucinations in Parkinson's disease: A
โœ Anne Doรฉ de Maindreville; Gilles Fรฉnelon; Florence Mahieux ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 125 KB ๐Ÿ‘ 1 views

## Abstract To study prevalence of hallucinations in patients with Parkinson's disease (PD) during a 1โ€year period, and identify factors predictive of the onset of hallucinations in patients who were hallucinationโ€free at baseline, 141 unselected outpatients with PD were evaluated prospectively for

Mortality in achondroplasia study: A 42-
โœ Julia Wynn; Terri M. King; Michael J. Gambello; D. Kim Waller; Jacqueline T. Hec ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 140 KB ๐Ÿ‘ 2 views